Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 1 Jan 2021

Liu Yuhong, Gao Jingtao, Du Jian, Shu Wei, Wang Lu, Wang Yufeng, Xue Zhongtan, Li Liang, Xu Shaofa, Pang Yu

Abstract excerpt

OBJECTIVES: We described the prevalence of clofazimine (CFZ) resistance in a multidrug-resistant tuberculosis (MDR-TB) cohort in China. We also aimed to identify dynamic changes in CFZ susceptibility and its molecular mechanism after exposure to bedaquiline (BDQ) and/or CFZ. METHODS: The experimental settings were conducted based on our MDR-TB cohort receiving BDQ-containing regimens. Sequential isolates were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Diarylquinolines

Share to Drug Resistance, Multiple, Bacterial

Share to Microbial Sensitivity Tests

Share to Mycobacterium tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 33130209
DOI: 10.1016/j.ijid.2020.10.081

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.PMID 33130209Read ↗

Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.Semantic proximity Read ↗

In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, ChinaSemantic proximity Read ↗

Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey.Semantic proximity Read ↗

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid CombinationSemantic proximity Read ↗

Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in PakistanSemantic proximity Read ↗

In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis.Semantic proximity Read ↗

In Vitro Drug Susceptibility of Bedaquiline, Delamanid, Linezolid, Clofazimine, Moxifloxacin, and Gatifloxacin against Extensively Drug-Resistant Tuberculosis in Beijing, China.Semantic proximity Read ↗

Prevalence of Extensively Drug-resistant Tuberculosis in a Chinese Multidrug-resistant TB Cohort after RedefinitionSemantic proximity Read ↗

Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinitionSemantic proximity Read ↗

Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in ChinaSemantic proximity Read ↗

Bedaquiline Resistance: Its Emergence, Mechanism, and PreventionSemantic proximity Read ↗

Global mapping of bedaquiline-resistant Mycobacterium tuberculosis: a systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.